180 related articles for article (PubMed ID: 25042151)
21. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
[TBL] [Abstract][Full Text] [Related]
22. Targeting tumor angiogenesis with histone deacetylase inhibitors: the hydroxamic acid derivative LBH589.
Qian DZ; Kato Y; Shabbeer S; Wei Y; Verheul HM; Salumbides B; Sanni T; Atadja P; Pili R
Clin Cancer Res; 2006 Jan; 12(2):634-42. PubMed ID: 16428510
[TBL] [Abstract][Full Text] [Related]
23. Targeting galectin-1 inhibits pancreatic cancer progression by modulating tumor-stroma crosstalk.
Orozco CA; Martinez-Bosch N; Guerrero PE; Vinaixa J; Dalotto-Moreno T; Iglesias M; Moreno M; Djurec M; Poirier F; Gabius HJ; Fernandez-Zapico ME; Hwang RF; Guerra C; Rabinovich GA; Navarro P
Proc Natl Acad Sci U S A; 2018 Apr; 115(16):E3769-E3778. PubMed ID: 29615514
[TBL] [Abstract][Full Text] [Related]
24. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
[TBL] [Abstract][Full Text] [Related]
25. Wnt inhibitory factor 1 induces apoptosis and inhibits cervical cancer growth, invasion and angiogenesis in vivo.
Ramachandran I; Thavathiru E; Ramalingam S; Natarajan G; Mills WK; Benbrook DM; Zuna R; Lightfoot S; Reis A; Anant S; Queimado L
Oncogene; 2012 May; 31(22):2725-37. PubMed ID: 22002305
[TBL] [Abstract][Full Text] [Related]
26. Effects of the Calix[4]arene Derivative Compound OTX008 on High Glucose-Stimulated ARPE-19 Cells: Focus on Galectin-1/TGF-β/EMT Pathway.
Trotta MC; Petrillo F; Gesualdo C; Rossi S; Corte AD; Váradi J; Fenyvesi F; D'Amico M; Hermenean A
Molecules; 2022 Jul; 27(15):. PubMed ID: 35897964
[TBL] [Abstract][Full Text] [Related]
27. First evidence that γ-tocotrienol inhibits the growth of human gastric cancer and chemosensitizes it to capecitabine in a xenograft mouse model through the modulation of NF-κB pathway.
Manu KA; Shanmugam MK; Ramachandran L; Li F; Fong CW; Kumar AP; Tan P; Sethi G
Clin Cancer Res; 2012 Apr; 18(8):2220-9. PubMed ID: 22351692
[TBL] [Abstract][Full Text] [Related]
28. A novel herbal formula induces cell cycle arrest and apoptosis in association with suppressing the PI3K/AKT pathway in human lung cancer A549 cells.
Xiong F; Jiang M; Huang Z; Chen M; Chen K; Zhou J; Yin L; Tang Y; Wang M; Ye L; Zhan Z; Duan J; Fu H; Zhang X
Integr Cancer Ther; 2014 Mar; 13(2):152-60. PubMed ID: 24105357
[TBL] [Abstract][Full Text] [Related]
29. Pien Tze Huang inhibits tumor angiogenesis in a mouse model of colorectal cancer via suppression of multiple cellular pathways.
Shen A; Lin J; Chen Y; Lin W; Liu L; Hong Z; Sferra TJ; Peng J
Oncol Rep; 2013 Oct; 30(4):1701-6. PubMed ID: 23843018
[TBL] [Abstract][Full Text] [Related]
30. Ursolic acid inhibits colorectal cancer angiogenesis through suppression of multiple signaling pathways.
Lin J; Chen Y; Wei L; Hong Z; Sferra TJ; Peng J
Int J Oncol; 2013 Nov; 43(5):1666-74. PubMed ID: 24042330
[TBL] [Abstract][Full Text] [Related]
31. Antitumor activities of JTP-74057 (GSK1120212), a novel MEK1/2 inhibitor, on colorectal cancer cell lines in vitro and in vivo.
Yamaguchi T; Kakefuda R; Tajima N; Sowa Y; Sakai T
Int J Oncol; 2011 Jul; 39(1):23-31. PubMed ID: 21523318
[TBL] [Abstract][Full Text] [Related]
32. Thrombospondin-1 peptide ABT-510 combined with valproic acid is an effective antiangiogenesis strategy in neuroblastoma.
Yang Q; Tian Y; Liu S; Zeine R; Chlenski A; Salwen HR; Henkin J; Cohn SL
Cancer Res; 2007 Feb; 67(4):1716-24. PubMed ID: 17308113
[TBL] [Abstract][Full Text] [Related]
33. Antitumor agent calixarene 0118 targets human galectin-1 as an allosteric inhibitor of carbohydrate binding.
Dings RP; Miller MC; Nesmelova I; Astorgues-Xerri L; Kumar N; Serova M; Chen X; Raymond E; Hoye TR; Mayo KH
J Med Chem; 2012 Jun; 55(11):5121-9. PubMed ID: 22575017
[TBL] [Abstract][Full Text] [Related]
34. A Novel Galectin-1 Inhibitor Discovered through One-Bead Two-Compound Library Potentiates the Antitumor Effects of Paclitaxel
Shih TC; Liu R; Fung G; Bhardwaj G; Ghosh PM; Lam KS
Mol Cancer Ther; 2017 Jul; 16(7):1212-1223. PubMed ID: 28396365
[TBL] [Abstract][Full Text] [Related]
35. Cathepsin L-induced galectin-1 may act as a proangiogenic factor in the metastasis of high-grade serous carcinoma.
Pranjol MZI; Zinovkin DA; Maskell ART; Stephens LJ; Achinovich SL; Los' DM; Nadyrov EA; Hannemann M; Gutowski NJ; Whatmore JL
J Transl Med; 2019 Jul; 17(1):216. PubMed ID: 31269957
[TBL] [Abstract][Full Text] [Related]
36. Novel analogs of antitumor agent calixarene 0118: Synthesis, cytotoxicity, click labeling with 2-[(18)F]fluoroethylazide, and in vivo evaluation.
Läppchen T; Dings RP; Rossin R; Simon JF; Visser TJ; Bakker M; Walhe P; van Mourik T; Donato K; van Beijnum JR; Griffioen AW; Lub J; Robillard MS; Mayo KH; Grüll H
Eur J Med Chem; 2015 Jan; 89():279-95. PubMed ID: 25462244
[TBL] [Abstract][Full Text] [Related]
37. The down-regulation of galectin-1 expression is a specific biomarker of arsenic toxicity.
Chang YY; Chiang MC; Kuo TC; Chi LL; Kao YH; Huang RN
Toxicol Lett; 2011 Aug; 205(1):38-46. PubMed ID: 21596116
[TBL] [Abstract][Full Text] [Related]
38. A key role for galectin-1 in sprouting angiogenesis revealed by novel rationally designed antibodies.
van Beijnum JR; Thijssen VL; Läppchen T; Wong TJ; Verel I; Engbersen M; Schulkens IA; Rossin R; Grüll H; Griffioen AW; Nowak-Sliwinska P
Int J Cancer; 2016 Aug; 139(4):824-35. PubMed ID: 27062254
[TBL] [Abstract][Full Text] [Related]
39. Galectin-3 inhibition suppresses drug resistance, motility, invasion and angiogenic potential in ovarian cancer.
Mirandola L; Yu Y; Cannon MJ; Jenkins MR; Rahman RL; Nguyen DD; Grizzi F; Cobos E; Figueroa JA; Chiriva-Internati M
Gynecol Oncol; 2014 Dec; 135(3):573-9. PubMed ID: 25284038
[TBL] [Abstract][Full Text] [Related]
40. Lactoferrin Exerts Antitumor Effects by Inhibiting Angiogenesis in a HT29 Human Colon Tumor Model.
Li HY; Li M; Luo CC; Wang JQ; Zheng N
J Agric Food Chem; 2017 Dec; 65(48):10464-10472. PubMed ID: 29112400
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]